Sinopharm begins phase 3 trial of Covid-19 inactivated vaccine candidate

This article was originally published here

The late-stage study of the Covid-19 inactivated vaccine candidate marks the first phase 3 clinical trial for any vaccine candidate being developed in the world against the novel

The post Sinopharm begins phase 3 trial of Covid-19 inactivated vaccine candidate appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply